Loading...
Docoh

Janux Therapeutics (JANX)

JANX stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

10 May 22
26 Jun 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 55.95M 55.95M 55.95M 55.95M 55.95M 55.95M
Cash burn (monthly) (no burn) 16.31M 4.51M 3.68M 3.84M 2.93M
Cash used (since last report) n/a 46.87M 12.97M 10.58M 11.04M 8.41M
Cash remaining n/a 9.08M 42.97M 45.36M 44.91M 47.53M
Runway (months of cash) n/a 0.6 9.5 12.3 11.7 16.2

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Jun 22 Jake Simson Stock Option Common Stock Grant Acquire A No No 10.73 12,500 134.13K 12,500
14 Jun 22 Lichter Jay Stock Option Common Stock Grant Acquire A No No 10.73 12,500 134.13K 12,500
14 Jun 22 Gujrathi Sheila Stock Option Common Stock Grant Acquire A No No 10.73 12,500 134.13K 12,500
14 Jun 22 Ra Capital Management Stock Option Common Stock Grant Acquire A Yes No 10.73 12,500 134.13K 12,500
14 Jun 22 Stefan Heller Stock Option Common Stock Grant Acquire A No No 10.73 12,500 134.13K 12,500
85.8% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 48 47 +2.1%
Opened positions 6 24 -75.0%
Closed positions 5 9 -44.4%
Increased positions 19 9 +111.1%
Reduced positions 9 8 +12.5%
13F shares Current Prev Q Change
Total value 694.52M 724.1M -4.1%
Total shares 35.73M 34.73M +2.9%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Ra Capital Management 8.67M $171.07M 0.0%
FMR 4.99M $98.48M +38.1%
Avalon Ventures XI 4.48M $83.23M 0.0%
Bregua 3.75M $69.66M 0.0%
Orbimed Advisors 2.84M $55.96M -18.2%
JHG Janus Henderson 2.4M $46.56M -0.6%
Citadel Advisors 1.85M $36.57M -0.3%
EcoR1 Capital 1.41M $27.86M 0.0%
BVF 1.02M $20.07M 0.0%
BLK Blackrock 1.01M $19.89M +25.8%
Largest transactions Shares Bought/sold Change
FMR 4.99M +1.38M +38.1%
Orbimed Advisors 2.84M -630K -18.2%
BLK Blackrock 1.01M +206.48K +25.8%
Cerity Partners 150.93K +150.93K NEW
SG Americas Securities 0 -65.41K EXIT
Logos Global Management 185.2K -61.93K -25.1%
Parametric Portfolio Associates 0 -59.37K EXIT
DekaBank Deutsche Girozentrale 45K +45K NEW
Janney Montgomery Scott 0 -40.86K EXIT
STT State Street 211.57K +36.92K +21.1%

Financial report summary

?

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. senior Avg